Targeted Therapy of Multiple Sclerosis: a Case for Antigen-specific Tregs

Abstract excerpt

Multiple sclerosis is an autoinflammatory condition that results in damage of myelinated neurons in affected patients. While disease-modifying treatments have been successful in slowing the progression of relapsing remittent disease, most patients still progress to secondary progressive disease that is largely unresponsive to disease-modifying treatments. Similarly, there is currently no effective treatment for pa...

Topics

Open a Topic to create a Post that cites this publication.

• Autoantibodies
• Central Nervous System
• Genetic Variation
• Immunosuppression Therapy
• Immunotherapy and Immune Responses
• Multiple Sclerosis
• Multiple Sclerosis Research Studies
• T-Lymphocytes

Identifiers and source

Literature Corpus work

d49337a8-ebb4-5dfc-b719-22297e5d867b

DOI

10.20944/preprints202404.0325.v1